M

Memphasys Ltd
ASX:MEM

Watchlist Manager
Memphasys Ltd
ASX:MEM
Watchlist
Price: 0.006 AUD Market Closed
Market Cap: AU$14.7m

Net Margin

-136 191.9%
Current
Declining
by 100 907.7%
vs 3-y average of -35 284.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-136 191.9%
=
Net Income
AU$-5m
/
Revenue
AU$3.7k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-136 191.9%
=
Net Income
AU$-5m
/
Revenue
AU$3.7k

Peer Comparison

Country Company Market Cap Net
Margin
AU
Memphasys Ltd
ASX:MEM
14.7m AUD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 96% of companies in Australia
Percentile
4rd
Based on 4 004 companies
4rd percentile
-136 191.9%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Memphasys Ltd
Glance View

Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The company develops medical devices, diagnostics and media with application to assists reproduction technologies in humans and animals. The Company’s lead product is Felix device. The Felix is an automated device for separating quality sperm from a semen sample for the use in human in vitro fertilization (IVF) procedures. The firm's membrane technology utilizes its separation technology along with its multiple devices and hydrogel membranes to fractionate biological molecules. The technology relies on the applied electric field and charged biological molecules. The sample and harvest chamber are formed by placing the separation membrane in between two restriction membranes with restricted pores.

MEM Intrinsic Value
4.0E-5 AUD
Overvaluation 99%
Intrinsic Value
Price
M
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-136 191.9%
=
Net Income
AU$-5m
/
Revenue
AU$3.7k
What is Memphasys Ltd's current Net Margin?

The current Net Margin for Memphasys Ltd is -136 191.9%, which is below its 3-year median of -35 284.2%.

How has Net Margin changed over time?

Over the last 3 years, Memphasys Ltd’s Net Margin has decreased from -7 654.4% to -136 191.9%. During this period, it reached a low of -136 191.9% on Jul 30, 2025 and a high of -7 654.4% on May 30, 2022.

Back to Top